Navigation Links
USP Inaugurates Expanded Shanghai Facility to Enhance Availability of Quality Standards for Medicines, Herbal Medicines/Dietary Supplements and Food Ingredients
Date:1/11/2014

e in an ever-shrinking world, which makes the quality of products made and sold in China just as important as the quality of products made and sold in the United States,” Williams said. “The global flow of products means that quality issues can have a wide impact and having a facility in China allows USP to work more closely with developments in this important industry.”

Williams added that the expanded presence in Shanghai is another step forward in a relationship whose groundwork was laid nearly a century ago, with the first translation of USP standards into Chinese in 1923.

In recent decades, USP outreach to China has intensified, starting with a 1990 visit to ChP. The following year, Mr. Wang Ping (currently the Deputy Secretary General of ChP) became the first Chinese scientist to participate in the newly established USP Visiting Scientists Program and the years since have seen the relationship continue to evolve and expand.

In inaugurating its new facility, USP expresses sincere appreciation to its hosts in China, which reflect a broad array of government bodies both centrally and in the district city of Shanghai, together with representatives from manufacturers, academicians and many other stakeholders from civil society.

For media inquiries, please email mediarelations (at) usp (dot) org.

---

USP – Global Expertise, Trusted Standards, Improved Health

The U.S. Pharmacopeial Convention (USP) is a global health organization that improves lives through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. USP’s standards are used worldwide. For more information about USP visit http://www.usp.org. FY1423

Read the full story at http://www.prweb.com/releases/2014-usp-shangh
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Tibet’s Health Minister Inaugurates Telemedicine for Tibetan Patients
2. Long Island Counsilman Inaugurates New Laser Center
3. Hearth and Home – Adult Day Healthcare Center Planning Expanded Services
4. Increase to Almost 40,000 Transvaginal Mesh Lawsuits in Federal Court Leads to Expanded Leadership Committee, Notes Rottenstein Law Group LLP
5. UCHealth Offers New, Expanded Health Plan Services for Employers
6. Gun retailers strongly support expanded criteria for denying gun purchases, UC Davis survey finds
7. San Francisco Health Plan’s Innovative Diabetes Text Messaging Program Expanded to Include Members Affected with Asthma
8. Footwear etc. Announces an Expanded Selection of Shoes in Varying Widths
9. Migraine Research Foundation Announces Newly Expanded and Updated Headache Doctor Lists
10. Expanded Life Skills Courses at Emerald Coast Rehab Contribute to High Success Rate
11. Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Carson Energy also announced they have ... transactions. AdvantaIRA Trust, LLC is the country’s largest self-directed ... fund positions using IRA’s does 2 things:, 1. It ... even if there current cash position will not allow ... for Carson and their investors to be able to ...
(Date:6/1/2015)... 01, 2015 The federal court overseeing ... amended the Case Management Order governing case selection for ... Amended Order which was issued in the U.S. ... 2015, directs the parties to submit a Proposed Case ... that outlines parameters and the process for selecting AbbVie-only ...
(Date:6/1/2015)... June 01, 2015 Atagi Plastic Surgery ... been named an Ultherapy® Ultra Treatment Provider ... and Skin Aesthetics is one of only six practices ... premier treatment provider. , Atagi Plastic Surgery and ... Denver area has led the practice to earn the ...
(Date:6/1/2015)... Washington, D.C. (PRWEB) June 01, 2015 Linda ... tired and had an irregular heartbeat. At first she thought ... soon found out it was much more than that. After ... valve disease. Linda admitted she felt afraid about what might ... as five million Americans are diagnosed with valve disease each ...
(Date:6/1/2015)... June 01, 2015 On May 14, ... center hosted the Cherry Creek Chamber of Commerce ... clinic. Urgent care centers typically do not offer primary ... AFC/Doctors Express Cherry Creek Urgent Care staff to schedule ... , From 5:30 to 7:30 p.m. the center hosted ...
Breaking Medicine News(10 mins):Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 3Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 4Health News:Atagi Plastic Surgery and Skin Aesthetics Named Ultherapy® Ultra Treatment Provider 2Health News:A New Online Resource for Those Living with Heart Valve Disease 2Health News:A New Online Resource for Those Living with Heart Valve Disease 3Health News:Grand Opening For AFC/Doctors Express Cherry Creek Primary Care Clinic 2
... of Michigan scientists have found that a deficiency in a key ... type of adult brain cancer. The study, conducted in mice that ... and a way to screen for the disease early. Appearing ... in mice show for the first time that:, Glioblastoma, the ...
... A closer look at regulatory and clinical concerns with ... to an educational advisory by the International Society for ... issue of The Journal of Heart and Lung ... Thoracic transplant patients ...
... Georgia to use a new, cutting edge diagnostic ... outcomes. , , WOBURN, Mass., and VEDBAEK, Denmark, ... Medical Center in Savannah, Georgia has implemented AdvanDx,s PNA FISH(R) ... than conventional methods to help their physicians, pharmacists and nurses ...
... addresses limitations of current randomized trials , , ... Inc . highlighted recent clinical panel presentations underscoring ... for treating asthma in adults and children. The company ... to mixed results in some randomized trials of eNO-guided ...
... Cordex Pharma, Inc. (OTC Bulletin Board: CDXP) announced ... has approved the design of pivotal, Phase 2b/3 clinical ... drug for the acute treatment of patients with paroxysmal ... process. , , ATPace(TM) is a novel ...
... China, June 2 /PRNewswire-Asia/ -- China Nepstar Chain Drugstore,Ltd. ... "Company"), the largest drugstore,chain in China based on the ... Mr. Jason (Xinghua) Wu as the Chief Operating,Officer. ... overseeing,procurement, logistics, store development and store operations. He ...
Cached Medicine News:Health News:Most common brain cancer may start in neural stem cells 2Health News:Most common brain cancer may start in neural stem cells 3Health News:Most common brain cancer may start in neural stem cells 4Health News:More stringent evaluation on the use of generic medications in thoracic transplantation 2Health News:Memorial University Medical Center (MUMC) Implements PNA FISH(R) Tests to Help Provide Best Care for Patients with Bloodstream Infections 2Health News:Memorial University Medical Center (MUMC) Implements PNA FISH(R) Tests to Help Provide Best Care for Patients with Bloodstream Infections 3Health News:Clinical Utility of Exhaled Nitric Oxide Highlighted By American Thoracic Society Panel 2Health News:Cordex Receives Special Protocol Assessment Approval from FDA for ATPace(TM) 2Health News:Cordex Receives Special Protocol Assessment Approval from FDA for ATPace(TM) 3Health News:Cordex Receives Special Protocol Assessment Approval from FDA for ATPace(TM) 4Health News:China Nepstar Chain Drugstore Appoints Chief Operating Officer 2Health News:China Nepstar Chain Drugstore Appoints Chief Operating Officer 3
(Date:6/1/2015)... MENLO PARK, Calif. , June 1, 2015 /PRNewswire/ ... medical device company that is providing innovative evidence-based solutions ... it has commenced an underwritten public offering of its ... by Nevro and 2,459,175 shares to be sold by ... grant the underwriters a 30-day option to purchase up ...
(Date:6/1/2015)... MENLO PARK, Calif. , June 1, ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical ... therapies in new orphan drug indications, today announced ... trial of  VAL-083  (dianhydrogalactitol) in patients with refractory ... form of human brain cancer. Results ...
(Date:6/1/2015)... CEFALY Technology , the creators of ... authorized for use prior to the onset of migraine ... trial showing that the Cefaly device returns normal metabolic ... patients, namely the orbitofrontal cortex and rostral cingulate. ... an imaging test of the brain, used a radioactive substance called a ...
Breaking Medicine Technology:Nevro Announces Proposed Public Offering of Common Stock 2Nevro Announces Proposed Public Offering of Common Stock 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 2DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 4DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 5DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 6DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 7DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 8New Study Shows CEFALY Returns Normal Metabolic Activity to Brain Areas in Migraine Patients 2
... Clinical Development for the Treatment of ... Opioid Bowel Dysfunction, ... presented positive results this week from Phase,1 and preclinical studies of ... in Las Vegas, Nevada. NKTR-118 is,Nektar,s proprietary oral therapy being studied ...
... physician leading clinical trials, FREEPORT, N.Y., ... in treating facial bruising from injectable cosmetic,treatments ... known for,treating under-eye circles. Pinoxide is ... (BMTd),created by AGI Dermatics and formulated in ...
Cached Medicine Technology:Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting 2Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting 3Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting 4Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting 5Promising Results in Treating Facial Bruising From Injectables 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: